It works in a similar way to naturally occurring corticosteroid hormones, reducing the activity of the immune system by attaching to receptors in various types of immune cell. (PDF/11.51 KB) (PDF/11.59 KB) (PDF/12.54 KB)



(PDF/397.63 KB)

(PDF/143.96 KB) Gueron B; Demoly P; Piercy J; Small M. A comparison of patients on Avamys vs Nasonex and Flixonase for Quality of Life and Symptoms Free Days in 3 European countries [Poster 380]. 1/5 over Nasonex 3. (PDF/34.68 KB) For the full list of all side effects reported with Avamys, see the package leaflet.Avamys should not be used in people who are allergic to fluticasone furoate or any of the other ingredients.The Committee for Medicinal Products for Human Use (CHMP) decided that Avamys’s benefits are greater than its risks for the treatment of the symptoms of allergic rhinitis in patients aged six years or over.


(PDF/74.41 KB) (PDF/143.08 KB) It is often accompanied by symptoms affecting the eyes, such as irritation, watering or redness. Using your allergy nasal spray properly is important. (PDF/408.75 KB) (PDF/642.66 KB) This is a summary of the European public assessment report (EPAR). (PDF/802.65 KB)

(PDF/439.07 KB)

(PDF/179.49 KB) (PDF/12.03 KB) Avamys was more effective than placebo at reducing symptoms of allergic rhinitis in patients aged six years and over.
(PDF/410.2 KB)

Avamys is for use in patients aged six years and over.The medicine can only be obtained with a prescription.The recommended dose of Avamys for patients aged 12 years and over is two sprays in each nostril once a day. (PDF/527.46 KB) (PDF/166.14 KB) (PDF/34.18 KB) Blow your nose gently, if needed; Shake the nasal spray; Remove the cap by gently squeezing the sides of the cap; Tilt your head forward; Place the nozzle in one of your nostrils; Point the …

(PDF/527.46 KB)

(PDF/33.71 KB) (PDF/403.95 KB) (PDF/11.59 KB) (PDF/12.08 KB) (PDF/80.94 KB) (PDF/33.83 KB)

How to use Avamys; See all videos.

(PDF/12.37 KB) (PDF/76.69 KB)

(PDF/396.26 KB) (PDF/154.1 KB) (PDF/12.07 KB)

In the studies of seasonal allergic rhinitis in patients aged 12 years or over, Avamys reduced symptom scores from around 9 points at the start of the study by between 3.6 and 5.4 points over two weeks, compared with a reduction of 2.3 to 3.7 points with placebo. (PDF/12.07 KB)